Dermatology Snapshots is sponsored by a educational grant from Abbivie. Feedback always welcome. Treatment algorithms for androgenetic alopeciaIs MTX drug survival increased with SC MTX vs Oral?What are the main skin features of Still’s Disease?GLP-1 receptor agonists and hair lossMetformin and doxycycline for HS: an RCTIdentifying patients at high risk of myeloproliferative disorders in aquagenic pruritus
All content for Dermatology Snapshots is the property of Dr Vanessa Pinder and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Dermatology Snapshots is sponsored by a educational grant from Abbivie. Feedback always welcome. Treatment algorithms for androgenetic alopeciaIs MTX drug survival increased with SC MTX vs Oral?What are the main skin features of Still’s Disease?GLP-1 receptor agonists and hair lossMetformin and doxycycline for HS: an RCTIdentifying patients at high risk of myeloproliferative disorders in aquagenic pruritus
Dermatology Snapshots is sponsored by a educational grant from Abbivie. Feedback always welcome. In this issue: IVIG for dermatomyositisFeatures of VEXAS syndrome Is it safe to use IL-23 inhibitors in patients with cancer?Decision fatigue with lesion superclinics?What’s Adams-Oliver syndrome?+ more…
Dermatology Snapshots
Dermatology Snapshots is sponsored by a educational grant from Abbivie. Feedback always welcome. Treatment algorithms for androgenetic alopeciaIs MTX drug survival increased with SC MTX vs Oral?What are the main skin features of Still’s Disease?GLP-1 receptor agonists and hair lossMetformin and doxycycline for HS: an RCTIdentifying patients at high risk of myeloproliferative disorders in aquagenic pruritus
